Iluvien 0.19 MG Drug Implant

DRUG2 trials

Sponsors

Imperial College London, Alimera Sciences

Conditions

DiabetesDiabetic Macular Edema

Phase 2

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

WithdrawnNCT03784443

Imperial College LondonDiabetes, Diabetic Macular Edema

Start: 2019-09-01End: 2023-09-01Updated: 2023-10-02

Phase 4

A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)

Active, not recruitingNCT04469595

Alimera SciencesDiabetic Macular Edema

Start: 2020-08-31End: 2024-12-31Target: 300Updated: 2024-07-31